TY - JOUR
T1 - Doxycycline hinders phenylalanine fibril assemblies revealing a potential novel therapeutic approach in phenylketonuria
AU - De Luigi, Ada
AU - Mariani, Alessandro
AU - De Paola, Massimiliano
AU - Re Depaolini, Andrea
AU - Colombo, Laura
AU - Russo, Luca
AU - Rondelli, Valeria
AU - Brocca, Paola
AU - Adler-Abramovich, Lihi
AU - Gazit, Ehud
AU - Del Favero, Elena
AU - Cantù, Laura
AU - Salmona, Mario
PY - 2015/10/29
Y1 - 2015/10/29
N2 - A new paradigm for the aetiopathology of phenylketonuria suggests the presence of amyloid-like assemblies in the brains of transgenic mouse models and patients with phenylketonuria, possibly shedding light on the selective cognitive deficit associated with this disease. Paralleling the amyloidogenic route that identifies different stages of peptide aggregation, corresponding to different levels of toxicity, we experimentally address for the first time, the physico-chemical properties of phenylalanine aggregates via Small Angle, Wide Angle X-ray Scattering and Atomic Force Microscopy. Results are consistent with the presence of well-structured, aligned fibres generated by milliMolar concentrations of phenylalanine. Moreover, the amyloid-modulating doxycycline agent affects the local structure of phenylalanine aggregates, preventing the formation of well-ordered crystalline structures. Phenylalanine assemblies prove toxic in vitro to immortalized cell lines and primary neuronal cells. Furthermore, these assemblies also cause dendritic sprouting alterations and synaptic protein impairment in neurons. Doxycycline counteracts these toxic effects, suggesting an approach for the development of future innovative non-dietary preventive therapies.
AB - A new paradigm for the aetiopathology of phenylketonuria suggests the presence of amyloid-like assemblies in the brains of transgenic mouse models and patients with phenylketonuria, possibly shedding light on the selective cognitive deficit associated with this disease. Paralleling the amyloidogenic route that identifies different stages of peptide aggregation, corresponding to different levels of toxicity, we experimentally address for the first time, the physico-chemical properties of phenylalanine aggregates via Small Angle, Wide Angle X-ray Scattering and Atomic Force Microscopy. Results are consistent with the presence of well-structured, aligned fibres generated by milliMolar concentrations of phenylalanine. Moreover, the amyloid-modulating doxycycline agent affects the local structure of phenylalanine aggregates, preventing the formation of well-ordered crystalline structures. Phenylalanine assemblies prove toxic in vitro to immortalized cell lines and primary neuronal cells. Furthermore, these assemblies also cause dendritic sprouting alterations and synaptic protein impairment in neurons. Doxycycline counteracts these toxic effects, suggesting an approach for the development of future innovative non-dietary preventive therapies.
UR - http://www.scopus.com/inward/record.url?scp=84946142361&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84946142361&partnerID=8YFLogxK
U2 - 10.1038/srep15902
DO - 10.1038/srep15902
M3 - Article
AN - SCOPUS:84946142361
VL - 5
JO - Scientific Reports
JF - Scientific Reports
SN - 2045-2322
M1 - 15902
ER -